Modelling Cortical Cataractogenesis 22: Is in vitro Reduction of Damage in Model Diabetic Rat Cataract by Taurine Due to Its Antioxidant Activity?
Authors:
- R. BhardwajRBR. Bhardwaj
- J. CaulfeildJCJ. Caulfeild
- J.R. TrevithickJTJ.R. Trevithick
- 1 September 1999
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 69 (3) , 291-300
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Aldose reductase: a window to the treatment of diabetic complications?Progress in Retinal and Eye Research, 1998
- Cyclic AMP-dependent up-regulation of the taurine transporter in a human retinal pigment epithelial cell lineCurrent Eye Research, 1995
- Expression and Regulation of the Taurine Transporter in Cultured Cell Lines of Human Origin1994
- Spin Trapping: ESR parameters of spin adducts 1474 1528VFree Radical Biology and Medicine, 1987
- Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataractCurrent Eye Research, 1984
- Studies on synthesis and uptake of taurine in rat lens in vitroExperimental Eye Research, 1983
- Distribution of taurine in the crystalline lens of vertebrate species and in cataractogenesisExperimental Eye Research, 1983
- H2O2-induced uncoupling of bovine lens Na+,K+-ATPase.Proceedings of the National Academy of Sciences, 1983
- Taurine in ocular tissues of vertebrate speciesExperimental Eye Research, 1981
- Cortical cataract formation prevented by vitamin E and glutathioneExperimental Eye Research, 1979